We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
376
Insmed
INSM
$27.6B
$409M 0.04%
14,372,685
+3,070,140
+27% +$91.1M
PHR icon
377
Phreesia
PHR
$780M
$409M 0.04%
6,668,399
+2,394,169
+56% +$125M
ACC
378
DELISTED
American Campus Communities, Inc.
ACC
$408M 0.04%
8,739,481
-163,280
-2% -$7.56M
MO icon
379
Altria Group
MO
$109B
$407M 0.04%
8,527,945
+206,748
+2% +$10.2M
BKU icon
380
Bankunited
BKU
$3.41B
$404M 0.04%
9,469,117
-237,492
-2% -$10.8M
NTRS icon
381
Northern Trust
NTRS
$34.8B
$403M 0.04%
3,483,410
-232,338
-6% -$26.6M
SYY icon
382
Sysco
SYY
$40B
$403M 0.04%
5,178,748
-32,825
-0.6% -$2.65M
NTLA icon
383
Intellia Therapeutics
NTLA
$1.66B
$403M 0.04%
2,486,491
+162,001
+7% +$12.6M
HDB icon
384
HDFC Bank
HDB
$119B
$400M 0.04%
10,951,390
+53,278
+0.5% +$1.95M
KSS icon
385
Kohl's
KSS
$2.22B
$399M 0.04%
7,235,273
-615,854
-8% -$35.4M
BPOP icon
386
Popular Inc
BPOP
$11.3B
$397M 0.04%
5,288,128
+82,196
+2% +$6.29M
NLSN
387
DELISTED
Nielsen Holdings plc
NLSN
$396M 0.04%
16,035,737
-604,535
-4% -$15.8M
MXIM
388
DELISTED
Maxim Integrated Products
MXIM
$394M 0.04%
3,735,433
-11,777,775
-76% -$1.15B
INTC icon
389
Intel
INTC
$527B
$393M 0.04%
6,994,386
-3,380,760
-33% -$198M
LDOS icon
390
Leidos
LDOS
$17.9B
$392M 0.04%
3,877,715
-76,219
-2% -$7.83M
FOX icon
391
Fox Class B
FOX
$24.4B
$390M 0.04%
11,073,238
-476,149
-4% -$17.2M
CCJ icon
392
Cameco
CCJ
$42.6B
$388M 0.04%
20,248,405
+275,404
+1% +$5.2M
PZZA icon
393
Papa John's
PZZA
$804M
$386M 0.04%
3,695,609
+61,685
+2% +$5.98M
DNLI icon
394
Denali Therapeutics
DNLI
$3.97B
$385M 0.04%
4,903,452
-1,154,827
-19% -$71.4M
PCG icon
395
PG&E
PCG
$38.5B
$382M 0.04%
37,543,043
+1,829,140
+5% +$19.6M
DAVA icon
396
Endava
DAVA
$167M
$381M 0.04%
3,363,121
+938,800
+39% +$90.8M
KMPR icon
397
Kemper
KMPR
$1.59B
$379M 0.04%
5,127,628
-833,076
-14% -$64.2M
BPMC
398
DELISTED
Blueprint Medicines
BPMC
$375M 0.03%
4,262,114
+212,840
+5% +$19.5M
LII icon
399
Lennox International
LII
$14.5B
$375M 0.03%
1,068,572
-15,665
-1% -$5.28M
REG icon
400
Regency Centers
REG
$14.1B
$373M 0.03%
5,826,976
-266,907
-4% -$16.9M

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.